Article
Characterization of First-line use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors in Metastatic Breast Cancer among Florida Health Care Systems
Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting
(2020)
Abstract
L. Raez; J. Unzaga; J. Garcia; K. Paranjpe; I. Arias; A. Castrellon
Disciplines
Publication Date
May 25, 2020
Citation Information
Reshma Mahtani. "Characterization of First-line use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors in Metastatic Breast Cancer among Florida Health Care Systems" Journal of Clinical Oncology / American Society of Clinical Oncology (ASCO) Annual Meeting Vol. 38 Iss. 15_suppl. (2020) Available at: http://works.bepress.com/reshma-mahtani/51/